online webinar 2019 - Understanding the FDA Aseptic Processing Guidance Document
Topics/Call fo Papers
Overview
Aseptically processing final drug product is a crucial step in the drug manufacturing process. Failures related to aseptic processing of a final drug product are detrimental to patients. In many cases, once a failure is discovered, the drug product is considered unfit for use and may be destroyed. By understanding and implementing the concepts described in the Aseptic Guidance document, – Sep 2004, many of the failures related to aseptic processing can be eliminated.
The process of aseptic filling final drug products is not an easy task. The FDA Aseptic Processing Guidance document gives guidance when it comes putting the proper procedures and controls into place for preventing harm to a patient related to aseptic processing. By understanding how final drug product is aseptically processed, pharmaceutical companies can implement many of the controls described in the FDA Guidance Document.
Session Highlights
Brief history of reason why the Aseptic processing guidance document is important,
Brief overview of the Aseptic Processing Guidance Document – Sep 2004.
Reviewing the concepts outlined in the Aseptic Guidance document and ways to implement the concepts described in the guidance document.
Examples on how the concepts outlined in the Aseptic Processing Guidance document can be implemented.
Who Will Benefit
Quality Assurance Managers and Directors
Quality Control Personnel
Supervisors, and Managers involved in Compounding Drug Products
Consultants
Regulatory and Compliance Management
Regulatory Affairs Professionals
Speaker
Carl Patterson is a seasoned Pharmaceutical Manufacturing, Aseptic Processing, and Quality Assurance Professional who is based in San Diego, California. As soon as he discovered the importance of biotechnology in the area, he was inspired to enter the pharmaceutical manufacturing industry. However, his avid interest in all things biology, microbiology, and biochemistry officially began when he served in the U.S. Army as a Preventative Medicine Specialist and a Licensed Vocational Nurse.
Furthermore, Carl holds various degrees and certifications, including an M.S. in Biomedical Quality Systems from San Diego State University, a B.S. in Microbiology from the University of Texas, and Specialized Certificates in QA/QC & Biotechnology from UCSD
Aseptically processing final drug product is a crucial step in the drug manufacturing process. Failures related to aseptic processing of a final drug product are detrimental to patients. In many cases, once a failure is discovered, the drug product is considered unfit for use and may be destroyed. By understanding and implementing the concepts described in the Aseptic Guidance document, – Sep 2004, many of the failures related to aseptic processing can be eliminated.
The process of aseptic filling final drug products is not an easy task. The FDA Aseptic Processing Guidance document gives guidance when it comes putting the proper procedures and controls into place for preventing harm to a patient related to aseptic processing. By understanding how final drug product is aseptically processed, pharmaceutical companies can implement many of the controls described in the FDA Guidance Document.
Session Highlights
Brief history of reason why the Aseptic processing guidance document is important,
Brief overview of the Aseptic Processing Guidance Document – Sep 2004.
Reviewing the concepts outlined in the Aseptic Guidance document and ways to implement the concepts described in the guidance document.
Examples on how the concepts outlined in the Aseptic Processing Guidance document can be implemented.
Who Will Benefit
Quality Assurance Managers and Directors
Quality Control Personnel
Supervisors, and Managers involved in Compounding Drug Products
Consultants
Regulatory and Compliance Management
Regulatory Affairs Professionals
Speaker
Carl Patterson is a seasoned Pharmaceutical Manufacturing, Aseptic Processing, and Quality Assurance Professional who is based in San Diego, California. As soon as he discovered the importance of biotechnology in the area, he was inspired to enter the pharmaceutical manufacturing industry. However, his avid interest in all things biology, microbiology, and biochemistry officially began when he served in the U.S. Army as a Preventative Medicine Specialist and a Licensed Vocational Nurse.
Furthermore, Carl holds various degrees and certifications, including an M.S. in Biomedical Quality Systems from San Diego State University, a B.S. in Microbiology from the University of Texas, and Specialized Certificates in QA/QC & Biotechnology from UCSD
Other CFPs
- Live Webinar 60 minutes Laboratory Developed Tests: Challenges and Opportunities
- 2019 90 mins. Webinar Effective Change Control Programs
- Controlling Human Error in the Manufacturing Floor
- Live Webinar FDA’s New Import Program for 2019 : Be Prepared and Be Compliant
- 2019 Live Webinar : Validation Essentials for Medical Device Manufacturers – IQ, OQ, PQ
Last modified: 2019-06-08 16:36:52